
Meghan Delaney Named Next CEO of New York Blood Center Enterprises
The Board of Trustees at New York Blood Center Enterprises has selected Meghan Delaney, DO, MPH, to lead the organization starting January 4, 2027. She succeeds Christopher D. Hillyer, MD, who steered the nonprofit through a significant expansion of its research, biomanufacturing, and life sciences investment capabilities over seventeen years.













:max_bytes(150000):strip_icc():focal(971x578:973x580)/angelina-jolie-james-haven-1-6f4cdc9a88e14f28b52fa0984999d037.jpg)






